Comments
Loading...
Kairos Pharma (KAPA) Forecast
NewsEarningsKairos Pharma (KAPA) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestKairos Pharma (AMEX:KAPA) Stock Quotes, Forecast and News Summary
Kairos Pharma Stock (AMEX: KAPA) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Kairos Pharma (KAPA) stock?
You can purchase shares of Kairos Pharma (AMEX:KAPA) through any online brokerage.
Who are Kairos Pharma (KAPA) competitors?
Other companies in Kairos Pharma’s space includes: NKGen Biotech (NASDAQ:NKGN), HOOKIPA Pharma (NASDAQ:HOOK), Curis (NASDAQ:CRIS), CARISMA Therapeutics (NASDAQ:CARM) and Nanoviricides (AMEX:NNVC).
What is the forecast, or price target, for Kairos Pharma (KAPA) stock?
Kairos Pharma has a consensus price target of $9.00.
What is the current price for Kairos Pharma (KAPA)?
The stock price for Kairos Pharma (AMEX: KAPA) is $1.655 last updated December 20, 2024 at 11:39 AM EST.
Does Kairos Pharma (KAPA) pay a dividend?
There are no upcoming dividends for Kairos Pharma.
When is Kairos Pharma (AMEX:KAPA) reporting earnings?
Kairos Pharma’s Q4 earnings are confirmed for Sunday, February 23, 2025.
Is Kairos Pharma (KAPA) going to split?
There is no upcoming split for Kairos Pharma.
What sector and industry does Kairos Pharma (KAPA) operate in?
Kairos Pharma is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.